Speciality: ENT
Description:
A warm welcome to all the medical professionals in this interesting session on Allegra M: The number 1 prescribed Fexofenadine-Montelukast (FM) brand in India.
Allegra M has emerged as the number one prescribed brand of Fexofenadine-Montelukast (FM) in India. This combination medication is widely recognized for its efficacy in managing allergic rhinitis and asthma, providing relief from symptoms like sneezing, runny nose, and wheezing. The brand's leading position underscores its popularity and trust among healthcare professionals and patients alike.
Allegra M combines Fexofenadine, a potent antihistamine, with Montelukast, a leukotriene receptor antagonist. This dual-action formula addresses multiple pathways involved in allergic reactions, making it highly effective for patients with co-existing respiratory conditions. By targeting both histamines and leukotrienes, Allegra M offers comprehensive symptom control, enhancing patient quality of life.
The widespread prescription of Allegra M reflects its clinical benefits, including rapid onset of action and sustained symptom relief. Patients report significant improvement in nasal congestion, sneezing, and bronchoconstriction, leading to better disease management and fewer exacerbations. Its well-tolerated profile also contributes to high patient adherence and satisfaction.
Therefore, get an overall knowledge of allegra M: The number 1 prescribed fexofenadine-montelukast (FM) brand in India.
See More Webinars @ Hidoc Webinars
1.
Cancer during young adulthood carries long-term mental toll, study finds
2.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
3.
Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC
4.
Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.
5.
Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit
1.
Exploring New Treatment Strategies for Mantle Cell Lymphoma
2.
Essential Techniques in Oncology and Quality Improvement
3.
Molecular Matching for Complex Blood Disorders
4.
Risk Assessment of Reduced Hematopoietic Reserve During Chronic Systemic Stress
5.
Oncology Team Communication Training for Clinical Learners
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
Breast Cancer Awareness and Early Detection
3.
How Advances in Cancer Research Are Improving Treatment Options
4.
Hands-on Workshop: Hematology
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation